YOLFTbeta
00

Boryung Pharm

003850 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

8,830.00KRW-50.00 (-0.56%)

Price History

Full chart

Market Stats

Previous Close8,880.00
Open8,860.00
Day Range8,830.00 – 8,910.00
52-Week Range7,410.00 – 10,800.00
Volume35.66K
Market Cap687.48B
P/E (TTM)0.00
Forward P/E27.55
Dividend Yield1.89%
Beta0.33
50-Day Avg8,672.40
200-Day Avg9,076.85

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jung-Gyun Kim
  • Employees0
  • HeadquartersBoryeong Building, Seoul, South Korea, 03127, Korea
  • Websitehttps://www.boryung.co.kr

Leadership

  • Mr. Jung-Gyun KimChairman & CEO · b. 1985
  • Daniel ChangChief Executive Officer of Pharma Biz
  • Mr. Sung Jin KimChief Strategy Officer & Director · b. 1987

Financials

Income Statement

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue267.84B300.96B308.01B312.08B409.14B422.72B460.40B524.27B561.87B627.28B760.48B859.63B1.02T1.02T
Growth (%)-+12.36%+2.34%+1.32%+31.10%+3.32%+8.91%+13.87%+7.17%+11.64%+21.23%+13.04%+18.32%+0.03%
Cost of Revenue159.42B179.63B181.64B185.73B232.53B254.90B271.79B301.27B330.42B362.34B453.29B506.20B653.75B645.14B
Gross Profit108.43B121.33B126.37B126.34B176.61B167.82B188.61B222.99B231.44B264.94B307.19B353.43B363.36B372.28B
Gross Margin40.48%40.31%41.03%40.48%43.17%39.70%40.97%42.53%41.19%42.24%40.39%41.11%35.72%36.59%
Operating Expense98.25B102.81B119.85B122.97B154.59B166.80B163.66B183.93B191.46B223.49B250.58B285.16B292.88B307.22B
Operating Income10.18B18.52B6.51B3.37B22.01B1.02B24.96B39.06B39.99B41.45B56.60B68.27B70.47B65.07B
Operating Margin3.80%6.15%2.12%1.08%5.38%0.24%5.42%7.45%7.12%6.61%7.44%7.94%6.93%6.40%
EBITDA-----93.00B42.81B59.96B66.95B107.27B102.64B110.24B114.81B124.95B
EBITDA Margin-----22.00%9.30%11.44%11.92%17.10%13.50%12.82%11.29%12.28%
Net Income5.18B14.35B6.18B9.40B5.61B56.70B20.31B32.22B26.86B43.04B41.89B40.20B69.63B64.30B
Net Income Margin1.93%4.77%2.01%3.01%1.37%13.41%4.41%6.15%4.78%6.86%5.51%4.68%6.85%6.32%
R&D17.52B17.34B25.56B28.23B28.96B32.28B34.43B37.86B35.51B39.15B41.71B47.29B51.47B65.09B
R&D as % of Total Revenue6.54%5.76%8.30%9.04%7.08%7.64%7.48%7.22%6.32%6.24%5.48%5.50%5.06%6.40%
Interest Expense00000096.55M62.13M3.34B4.48B6.13B9.55B9.00B11.58B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.02%0.01%0.59%0.71%0.81%1.11%0.88%1.14%

Balance Sheet

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets176.79B245.86B262.39B273.01B397.90B402.52B450.02B507.63B647.99B828.64B892.39B915.51B1.16T1.39T
Total Liabilities52.77B109.45B124.42B127.21B202.55B152.86B193.91B224.68B307.71B354.33B375.97B366.26B379.58B542.38B
Total Equity124.01B136.41B137.97B145.79B195.35B249.65B256.10B282.95B339.91B473.86B515.92B548.75B784.50B845.50B
Cash1.30B1.71B1.97B10.49B26.35B16.38B7.62B4.52B25.53B150.71B16.07B16.46B187.18B227.61B
Net Debt-----49.91B78.49B93.35B164.63B64.04B191.05B185.86B-83.54B

Cash Flow

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.59B24.12B9.19B18.38B9.36B-24.61B38.91B47.00B44.74B60.17B27.81B42.22B80.56B133.18B
Investing Cash Flow-10.45B-38.04B-14.15B-6.58B32.39B-24.54B-56.40B-59.12B-144.52B-47.76B-147.65B---
Financing Cash Flow3.75B13.23B5.23B-3.24B-38.52B39.47B8.65B8.96B121.43B111.99B-14.65B---
Capital Expenditure11.28B29.77B14.16B9.98B26.83B62.95B54.83B67.02B18.27B16.13B20.28B23.35B20.05B29.94B
Free Cash Flow------91.30B-18.21B-21.76B-11.85B849.90M-95.18B18.88B60.51B103.24B
Dividends Paid1.16B1.18B1.86B648.17M1.56B1.62B6.80B2.52B4.20B4.51B6.59B6.59B6.77B8.40B
FCF to OCF-----370.92%-46.81%-46.29%-26.50%1.41%-342.21%44.70%75.11%77.52%
Dividend Paid to FCF------1.77%-37.33%-11.59%-35.46%530.78%-6.92%34.89%11.18%8.13%

Earnings

Report DateNov 22, 2004May 2, 2005Aug 16, 2005Aug 14, 2006Nov 14, 2006May 15, 2007Aug 13, 2007Jan 28, 2008Jun 3, 2009Sep 2, 2009Dec 2, 2009Feb 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Feb 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 1, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Jan 30, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Jan 29, 2014May 28, 2014Sep 3, 2014Oct 27, 2014Jan 30, 2015Apr 27, 2015Jul 27, 2015Oct 29, 2015Feb 17, 2016Apr 29, 2016Jul 25, 2016Oct 28, 2016Jan 26, 2017Apr 25, 2017Jul 28, 2017Oct 26, 2017Jan 31, 2018Apr 27, 2018Jul 24, 2018Oct 29, 2018Jan 29, 2019Apr 22, 2019Jul 22, 2019Oct 28, 2019Jan 30, 2020Apr 23, 2020Jul 27, 2020Oct 27, 2020Feb 4, 2021May 14, 2021Jul 27, 2021Oct 26, 2021Feb 10, 2022Apr 27, 2022Jul 26, 2022Oct 24, 2022Feb 6, 2023Apr 27, 2023Jul 27, 2023Oct 25, 2023Jan 29, 2024Apr 30, 2024Jul 31, 2024Oct 28, 2024Feb 3, 2025Apr 29, 2025Jul 29, 2025Oct 27, 2025Dec 31, 2025Apr 28, 2026Jun 30, 2026
EPS Estimate59.1019.0146.1661.7945.8941.9940.8357.36---------------------------1200.19852.79143.34145.24157.20120.40167.90135.201403.40105.60---------------------------------
EPS Actual5.6019.20-12.9863.39-20.0435.2140.965.2231.1855.4512.62-11.5726.07106.5891.42-18.2666.1627.1014.411.8535.2638.5836.3553.5816.62164.57-18.8773.52101.6456.05103.92112.1392.9292.3495.0671.25372.15202.1675.57-239.0061.2016.0071.00131.8030.4074.00115.00131.85191.86179.23138.9194.16146.81108.99124.5686.75326.41-42.70316.0084.19170.00229.00332.19-96.24-96.25171.83181.2084.96354.92358.68141.90162.384.15105.57404.92249.65493.44286.58
Surprise-90.52%1.00%-128.12%2.59%-143.67%-16.15%0.32%-90.90%----------------------------94.06%-56.36%41.04%-47.97%-252.04%-49.17%-90.47%-47.49%-90.61%-71.21%---------------------------------
TimingAfter-hoursAfter-hours-Pre-market-Pre-marketAfter-hoursPre-market----------------------Pre-market-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hours-Pre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap687.48B
Enterprise Value950.40B
Trailing P/E0.00
Forward P/E27.55
PEG Ratio0.00
Price / Sales0.65
Price / Book0.78
Revenue (TTM)1.06T
Gross Profit (TTM)387.40B
EBITDA120.13B
Profit Margin11.37%
Operating Margin8.51%
Return on Equity14.38%
Return on Assets3.19%
Shares Outstanding81.75M
Shares Float28.26M
Beta0.33
Dividend Yield1.89%
Dividend Rate160.00
Payout Ratio11.15%

Dividends

20251×
160.00Dec 29, 2025
20241×
100.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
74.30Dec 29, 2020
20191×
74.30Dec 27, 2019
20181×
44.58Dec 27, 2018
20171×
118.88Dec 27, 2017
20161×
28.29Dec 28, 2016
20151×
26.94Dec 29, 2015
20141×
25.65Dec 29, 2014
20131×
18.32Dec 27, 2013
20121×
17.44Dec 27, 2012
20111×
11.63Dec 28, 2011
20101×
31.64Dec 29, 2010
20091×
21.09Dec 29, 2009
20081×
20.08Dec 29, 2008
20071×
24.58Dec 27, 2007
20061×
12.04Dec 27, 2006
20051×
14.16Dec 28, 2005
20041×
23.11Dec 29, 2004
20031×
18.48Dec 29, 2003
20021×
27.08Dec 27, 2002

Stock Splits

  • Jul 16, 20211.2:1
  • Dec 29, 20201.0998:1
  • Apr 30, 20185:1
  • Dec 28, 20161.0507:1
  • Dec 29, 20151.0501:1
  • Dec 29, 20141.0502:1
  • Dec 27, 20131.0502:1
  • Dec 27, 20121.05:1
  • Dec 28, 20111.0501:1
  • Dec 29, 20101.05:1
  • Apr 19, 20102:1